Food and Drug Administration

Gastrointestinal Drugs Advisory Committee with the Risk Management Subcommittee of the Advisory Committee for Pharmaceutical Science

April 23, 2002

Briefing Information



The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

GlaxoSmithKline, Background Information   pdf

Bibliography   pdf

Food and Drug Administration

Briefing Information   pdf